OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2022-10-31-accounts

REGISTERED CHARITY NUMBER: 1101433

Report of the Trustees and

Financial Statements

for the Year Ended 31 October 2022
for

EPSOM MEDICAL RESEARCH

Sandison Lang Limited
2 St Marys Road
Tonbridge
Kent
TN9 2LB

EPSOM MEDICAL RESEARCH

Contents of the Financial Statements
for the Year Ended 31 October 2022
Page
Report of the Trustees 1 to 2
Independent Examiner's Report 3
Statement of Financial Activities 4
Balance Sheet 5
Notes to the Financial Statements 6 to 10
Detailed Statement of Financial Activities 11

EPSOM MEDICAL RESEARCH

Report of the Trustees

for the Year Ended 31 October 2022

Thetrusteespresenttheirreportwiththefinancialstatementsofthecharityfortheyear ended
31October2022.ThetrusteeshaveadoptedtheprovisionsofAccountingandReportingby Charities:
StatementofRecommendedPracticeapplicabletocharitiespreparingtheiraccountsinaccordance with
the FinancialReportingStandardapplicablein the UK and Republicof Ireland(FRS 102)(effective1  January
2019).

OBJECTIVES AND ACTIVITIES

Objectives and aims

TheobjectivesoftheEpsomMedicalResearchareinthefieldofresearchwithintheareas of
rheumatology, general medicine, inflammation, neuroscience and cancer.

ACHIEVEMENT AND PERFORMANCE

Charitable activities in the year

The Charity supported research into the areas defined in its objectives during the year.

FINANCIAL REVIEW

Reserves policy

The Charity ensures it has sufficient reserves to cover any upcoming financial obligations.

STRUCTURE, GOVERNANCE AND MANAGEMENT

Governing document

Thecharityiscontrolledbyitsgoverningdocument,adeedoftrustandconstitutesan unincorporated
charity.

REFERENCE AND ADMINISTRATIVE DETAILS Registered Charity number

1101433

Principal address

85 Rydens Road
Elmbridge
Walton-on-Thames
Surrey
KT12 3AN

Trustees

Dr. L G Darlington
Ms S Kumar
K W D Ramsey

Independent Examiner

Sandison Lang Limited
2 St Marys Road
Tonbridge
Kent
TN9 2LB
Page 1

EPSOM MEDICAL RESEARCH

Report of the Trustees

for the Year Ended 31 October 2022
Approved by order of the board of trustees on ............................................. and signed on its behalf by:
.................................................................
Dr. L G Darlington - Trustee
Page 2
Independent Examiner's Report to the Trustees of
Epsom Medical Research

Independent examiner's report to the trustees of Epsom Medical Research

I reporttothecharitytrusteesonmyexaminationoftheaccountsofEpsomMedicalResearch(the Trust)
for the year ended 31 October 2022.

Responsibilities and basis of report

AsthecharitytrusteesoftheTrustyouareresponsibleforthepreparationoftheaccountsin accordance
with the requirements of the Charities Act 2011 ('the Act').
I reportin respectof myexaminationof theTrust'saccountscarriedoutunderSection145of theAct and
incarryingoutmyexaminationIhavefollowedallapplicableDirectionsgivenbytheCharity Commission
under Section 145(5)(b) of the Act.

Independent examiner's statement

Ihavecompletedmyexamination.Iconfirmthatnomaterialmattershavecometomyattention in
connection with the examination giving me cause to believe that in any material respect:

1. accounting records were not kept in respect of the Trust as required by Section 130 of the Act; or

2. the accounts do not accord with those records; or

3. the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination.

Ihavenoconcernsandhavecomeacrossnoothermattersinconnectionwiththeexaminationto which
attentionshouldbedrawninthisreportinordertoenableaproperunderstandingoftheaccountsto be
reached.
Mr Ryan Cottington, ACA, FCCA
Sandison Lang Limited
2 St Marys Road
Tonbridge
Kent
TN9 2LB
Date: .............................................
Page 3

EPSOM MEDICAL RESEARCH

Statement of Financial Activities

for the Year Ended 31 October 2022

2022
Unrestricted
fund
Notes
£
INCOME AND ENDOWMENTS FROM
Donations and legacies
62,000
EXPENDITURE ON
Charitable activities
Grants
44,207
Other
1,008
Total
45,215
NET INCOME
16,785
RECONCILIATION OF FUNDS
Total funds brought forward
(205,354)
TOTAL FUNDS CARRIED FORWARD
(188,569)
2021
Total
funds
£
47,105
37,276
1,645
38,921
8,184
(213,538)
(205,354)
The notes form part of these financial statements
Page 4

EPSOM MEDICAL RESEARCH

Balance Sheet

31 October 2022

2022
Unrestricted
fund
Notes
£
CURRENT ASSETS
Debtors
4
20,820
Cash at bank
229
21,049
CREDITORS
Amounts falling due within one year
5
(209,618)
NET CURRENT ASSETS/(LIABILITIES)
(188,569)
TOTAL ASSETS LESS CURRENT LIABILITIES
(188,569)
NET ASSETS/(LIABILITIES)
(188,569)
FUNDS
6
Unrestricted funds
(188,569)
TOTAL FUNDS
(188,569)
2021
Total
funds
£
8,420
14,496
22,916
(228,270)
(205,354)
(205,354)
(205,354)
(205,354)
(205,354)
ThefinancialstatementswereapprovedbytheBoardofTrusteesandauthorisedforissue on
............................................. and were signed on its behalf by:
.............................................
L G Darlington - Trustee
The notes form part of these financial statements
Page 5
EPSOM MEDICAL RESEARCH
Notes to the Financial Statements
for the Year Ended 31 October 2022

1. ACCOUNTING POLICIES

Basis of preparing the financial statements

Thefinancialstatementsofthecharity,whichisapublicbenefitentityunderFRS102,have been
preparedinaccordancewiththeCharitiesSORP(FRS102)'AccountingandReportingby Charities:
StatementofRecommendedPracticeapplicabletocharitiespreparingtheiraccountsin accordance
withtheFinancialReportingStandardapplicableintheUKandRepublicofIreland(FRS 102)
(effective1January2019)',FinancialReportingStandard102'TheFinancialReporting Standard
applicableintheUKandRepublicofIreland'andtheCharitiesAct2011.Thefinancial statements
have been prepared under the historical cost convention.

Income

Allincomeis recognisedin theStatementofFinancialActivitiesoncethecharityhasentitlement to
the funds, it is probable that the income will be received and the amount can be measured reliably.

Expenditure

Liabilitiesarerecognisedasexpenditureassoonasthereisalegalorconstructive obligation
committingthe charityto that expenditure,it is probablethat a transferof economicbenefitswill be
requiredinsettlementandtheamountoftheobligationcanbemeasuredreliably.Expenditure is
accountedforonanaccrualsbasisandhasbeenclassifiedunderheadingsthataggregateall cost
relatedtothecategory.Wherecostscannotbedirectlyattributedtoparticularheadingsthey have
been allocated to activities on a basis consistent with the use of resources.
Grantsofferedsubjecttoconditionswhichhavenotbeenmetattheyearenddatearenotedas a
commitment but not accrued as expenditure.

Taxation

The charity is exempt from tax on its charitable activities.

Fund accounting

Unrestrictedfundscanbe usedin accordancewiththecharitableobjectivesat thediscretionof the
trustees.
Restrictedfunds can only be used for particularrestrictedpurposeswithin the objectsof the  charity.
Restrictionsarisewhenspecifiedbythedonororwhenfundsareraisedforparticular restricted
purposes.
Furtherexplanationofthenatureandpurposeofeachfundis includedin thenotestothe financial
statements.
continued...
Page 6
EPSOM MEDICAL RESEARCH
Notes to the Financial Statements - continued
for the Year Ended 31 October 2022

2. TRUSTEES' REMUNERATION AND BENEFITS

Therewere no trustees'remunerationor otherbenefitsfor the yearended 31 October2022nor for
the year ended 31 October 2021.

Trustees' expenses

Therewerenotrustees'expensespaidfortheyearended31October2022norfortheyear ended
31 October 2021.

3. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES

Unrestricted
fund
£
INCOME AND ENDOWMENTS FROM
Donations and legacies 47,105
EXPENDITURE ON
Charitable activities
Grants 37,276
Other 1,645
Total 38,921
NET INCOME 8,184
RECONCILIATION OF FUNDS
Total funds brought forward (213,538)
TOTAL FUNDS CARRIED FORWARD (205,354)
continued...
Page 7
EPSOM MEDICAL RESEARCH
Notes to the Financial Statements - continued
for the Year Ended 31 October 2022
4.
DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
Other debtors
5.
CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
Other creditors
Accruals and deferred income
6.
MOVEMENT IN FUNDS
At
1/11/21
£
Unrestricted funds
General fund
(205,354)
TOTAL FUNDS
(205,354)
Net movement in funds, included in the above are as follows:
Incoming
resources
£
Unrestricted funds
General fund
62,000
TOTAL FUNDS
62,000
2022
2021
£
£
20,820
8,420
2022
2021
£
£
208,610
208,610
1,008
19,660
209,618
228,270
Net
movement
At
in funds
31/10/22
£
£
16,785
(188,569)
16,785
(188,569)
Resources
Movement
expended
in funds
£
£
(45,215)
16,785
(45,215)
16,785
continued...
Page 8
EPSOM MEDICAL RESEARCH
Notes to the Financial Statements - continued
for the Year Ended 31 October 2022

6. MOVEMENT IN FUNDS - continued

Comparatives for movement in funds

Unrestricted funds
General fund
TOTAL FUNDS
At
1/11/20
£
(213,538)
(213,538)
Net
movement
in funds
£
8,184
8,184
At
31/10/21
£
(205,354)
(205,354)
Comparative net movement in funds, included in the above are as follows:
Unrestricted funds
General fund
TOTAL FUNDS
Incoming
Resources
Movement
resources
expended
in funds
£
£
£
47,105
(38,921)
8,184
47,105
(38,921)
8,184
A current year 12 months and prior year 12 months combined position is as follows:
Unrestricted funds
General fund
TOTAL FUNDS
At
1/11/20
£
(213,538)
(213,538)
Net
movement
in funds
£
24,969
24,969
At
31/10/22
£
(188,569)
(188,569)
continued...
Page 9
Notes to the Financial Statements - continued
for the Year Ended 31 October 2022

EPSOM MEDICAL RESEARCH

6. MOVEMENT IN FUNDS - continued

Acurrentyear12monthsandprioryear12monthscombinednetmovementinfunds,included in
the above are as follows:
Incoming Resources Movement
resources expended in funds
£ £ £
Unrestricted funds
General fund 109,105 (84,136) 24,969
TOTAL FUNDS 109,105 (84,136) 24,969

7. RELATED PARTY DISCLOSURES

There were no related party transactions for the year ended 31 October 2022.
Page 10

EPSOM MEDICAL RESEARCH

Detailed Statement of Financial Activities for the Year Ended 31 October 2022

INCOME AND ENDOWMENTS
Donations and legacies
Donations
Gift aid
Legacies
Total incoming resources
EXPENDITURE
Charitable activities
Research salaries
Research expenses
Support costs
Governance costs
Accountancy and legal fees
Total resources expended
Net income
2022
£
49,600
12,400
-
62,000
62,000
31,655
12,552
44,207
1,008
45,215
16,785
2021
£
33,682
8,423
5,000
47,105
47,105
32,300
4,976
37,276
1,645
38,921
8,184
This page does not form part of the statutory financial statements
Page 11